Representation of the Body for Patients With Cancer (CORCAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01560533
Recruitment Status : Completed
First Posted : March 22, 2012
Last Update Posted : January 30, 2014
Information provided by (Responsible Party):
Hospices Civils de Lyon

Brief Summary:

The project aims to understand better how patients live the event of cancer and live its consequences on their bodily representations. In the study, the dynamic of the body image is not restricted to appearance but include sensations and visions of the inner body, what explains the choice of peritoneal cancer, and the treatment by cytoreductive surgery and HIPEC.

The three objectives of the study are:

  • identifying the impact of the representations of the treated body on the psychological strategies to cope with the disease, the bodily changes and the prospects of life;
  • making explicit the positive or negative impacts of these representations on the relationship between patients and health professionals (easing factors, misunderstandings, negotiations, etc.);
  • associating the health professionals with the study in its course and evaluation in order to elaborate a methodological collaborative approach between patients, health professionals and researchers in social sciences.

Condition or disease Intervention/treatment Phase
Peritoneal Carcinomatosis Behavioral: Interviews Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 21 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Representation of the Body and Treatment of Peritoneal Cancer by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - A Collaborative Approach Between Professionals of Health / Patients / Researchers
Study Start Date : November 2011
Actual Primary Completion Date : January 2013
Actual Study Completion Date : January 2013

Arm Intervention/treatment
Treated by HIPEC
Patients treated by HIPEC for peritoneal cancer
Behavioral: Interviews
Interviews will be done with patients

Standard chemiotherapy
Patients treated by standard chemiotherapy for peritoneal cancer
Behavioral: Interviews
Interviews will be done with patients

Primary Outcome Measures :
  1. Body representations [ Time Frame: 3 months ]

    Comprehensive knowledge concerning the way the patients are living cancer event, treatment, changes in their body representations and conceptions of their lives.

    This qualitative study do not include outcome measures. Its purpose is restricted to the meanings

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients eligible to treatment of cancer by cytoreductive surgery and HIPEC
  • Primary (pseudomyxoma, mesothelioma) and secondary (colorectal, gastric, ovarian) peritoneal cancer
  • Free consent
  • Male or Female
  • Age > 18 years
  • Affiliate to social security

Exclusion Criteria:

  • Age < 18 years, no french speaking
  • Cerebrals metastasis
  • Psychiatrics diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01560533

Centre Hospitalier Lyon Sud
Pierre Bénite, France, 69495
Sponsors and Collaborators
Hospices Civils de Lyon
Principal Investigator: Olivier GLEHEN, Pr Hospices Civiles de Lyon

Responsible Party: Hospices Civils de Lyon Identifier: NCT01560533     History of Changes
Other Study ID Numbers: 2010.640
First Posted: March 22, 2012    Key Record Dates
Last Update Posted: January 30, 2014
Last Verified: January 2014

Additional relevant MeSH terms:
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type